Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950137-02-002588
Filing Date
2002-04-30
Accepted
2002-04-30 17:26:12
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT c69238a1e10-ka.txt 10-K/A 238833
3 EXHIBIT 10.17 c69238a1ex10-17.txt EX-10.17 40321
4 EXHIBIT 10.18 c69238a1ex10-18.txt EX-10.18 37767
5 EXHIBIT 10.19 c69238a1ex10-19.txt EX-10.19 20240
6 EXHIBIT 10.20 c69238a1ex10-20.txt EX-10.20 16965
7 EXHIBIT 10.21 c69238a1ex10-21.txt EX-10.21 5990
8 EXHIBIT 10.22 c69238a1ex10-22.txt EX-10.22 72209
9 EXHIBIT 21.1 c69238a1ex21-1.txt EX-21.1 373
  Complete submission text file 0000950137-02-002588.txt   435058
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069 8472363800
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-13976 | Film No.: 02628239
SIC: 2834 Pharmaceutical Preparations